Friess Associates LLC P Lx Pharma Inc. Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$3.54 - $8.3 $984,371 - $2.31 Million	-278,071 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.69 - $19.66 $757,365 - $1.94 Million	-98,487 Reduced 26.15%	278,071 $2.23 Million
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $166,631 - $290,174	13,636 Added 3.76%	376,558 $7.27 Million
Q2 2021 Aug 11, 2021	BUY	$9.0 - $15.94 $535,698 - $948,780	59,522 Added 19.62%	362,922 $5.01 Million
Q1 2021 May 14, 2021	BUY	$5.24 - $10.14 $1.59 Million - $3.08 Million	303,400 New	303,400 $2.74 Million

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.